
Calgary teen trying to develop a way to prevent genetic defects before birth
Logan Cyr, 16, is working on a project that involves genetic editing to help prevent various genetic disorders.
It's a challenge typically reserved for biologists and researchers with their master's degrees, but 16-year-old Logan Cyr is hoping to develop a way to prevent genetic malformations before birth.
Cyr is in Grade 11 at STEM Innovations Academy High School in Calgary, but is also enrolled in The Knowledge Society (TKS) based out of Toronto.
On its website, TKS is described as a 10-month global training program for the world's most ambitious entrepreneurs and innovators.
Cyr says he had no interest in biology before getting into TKS, but now spends every available moment emersed in it
'If you could control how your brain develops during development, everyone would just have equally functional brains,' he said. 'Nobody would need to have like a memory disorder or be prone to Alzheimer's or anything like that; it's just due to getting unlucky while you're developing, it could all just be streamlined, and everyone would have the same chance at life.'
Cyr's interest in the topic was prompted by his mom's recent kidney failure.
She was born with one kidney, and it stopped working in 2019. She's been in hospital for the past seven months.
'This is actually the sixth time she's gone in – this time it was to get a new kidney – but it did not work, and she's been put back, and after the incision, she just hasn't fully recovered yet,' he said.
Cyr says he and his sister also have genetic disorders, and he says advances in genetic editing are making it possible to correct those disorders at an early age.
'I can apply it to kidneys, so I can prevent kidneys from not forming when you're still in the fetal phase,' he said. 'So, someone like my mom, where she was only born one kidney, that's because the kidney had a mutation and then either didn't become a kidney or died, so that cell just never became a kidney like it was supposed to.'
Azar Chatur is a director and coach at KTS, and says in Calgary there are close to 70 students enrolled in the program.
'We are the top youth innovation program for students who are between the ages of 13 and 18-years-old who are still in high school or middle school,' he said. 'We help students work on projects that they're really passionate about, excited about.'
Chatur says TKS is a benefit to students who are curious – and not just focused on achieving good grades in the school system.
'Most teenagers are really focused on grades and trying to get a certain grade because they have to get the grade to graduate from high school, and get into university, and things like that,' he said. 'But what that does is that limits their ability to be creative and explore things.'
Chatur says Cyr is the perfect candidate for the program, and example of how a student can achieve great things when they put their minds to it.
'Logan's a very smart young man,' he said. 'I think where TCS really helped him was with giving him that sense of direction, as well as just the belief that he can solve problems that are really important to him.'
Cyr says advancements in genetic editing are being made every minute, and he says what's being developed now is not far off from science fiction, even the Tony Stark character and the technology he used to create Iron Man.
'Let's say your baby has very weak lungs – maybe your baby has asthma and he's having issues breathing – so the doctor can go walk over and consult their coworker who could go on a tablet, they can 'Tony Stark' their whole toehold sensor for this specific application right there on site,' he said. 'And produce a solution for this specific case right there for that specific patient.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Globe and Mail
39 minutes ago
- Globe and Mail
Biochips Market Projected to Reach USD 37.73 Bn by 2032, Growing at 16.0% CAGR
Biochips Market, By Product Type (DNA Chips, Protein Chips, Lab-on-chip Tissue Arrays, Cell Arrays), By End User (Biotechnology and Pharmaceutical Companies, Academic & Research Institutes, Hospitals and Diagnostic Centers, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) According to a recent report by Coherent Market Insights, Global Biochips market is estimated to be valued at USD 13.34 Bn in 2025 and is expected to reach USD 37.73 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 16.0% from 2025 to 2032. Increasing application of biochips in the field of proteomics, genomics and drug discovery can drive the market growth. Extensive R&D activities in the field of healthcare and growing demand for point-of-care testing and diagnostics can also boost demand for biochips during the forecast period. Global Biochips Market Key Takeaways According to Coherent Market Insights (CMI), the global biochips market size is projected to grow at a robust CAGR of 16%, from USD 13.34 Bn in 2025 to USD 37.73 Bn by 2032. Based on product type, DNA chips segment is expected to account for over two-fifths of the global biochips market in 2025. By end user, biotechnology and pharmaceuticals segment will likely hold a market share of 35.1% by 2025. North America is anticipated to retain its dominance, holding a market share of nearly 2/5 in 2025. As per CMIs' new biochips market analysis, Asia Pacific is expected to experience fastest growth during the forecast period. Growing Demand for Personalized Medicine Boosting Market Growth Coherent Market Insights' latest biochips market research report highlights major factors driving industry growth. One such prominent growth factor is the increasing demand for personalized medicine. Biochips are a key enabling technology in personalized medicine. They enable rapid and accurate analysis of an individual's genetic and proteomic profiles. This supports pharmacogenomics, helps in creating tailored treatment plans, and facilitates targeted therapies. These capabilities are especially valuable in managing complex diseases such as cancer. Thus, growing interest in personalized medicine will continue to provide a strong impetus for the growth of biochips market in the coming years. High Cost of Biochips and Adoption of Alternative Technologies Limiting Market Growth The future biochips market outlook looks promising. However, high cost of bioships and associated equipment, along with growing usage of alternative technologies, remain a significant barrier to broader market growth. Biochips are quite expensive due to their complex manufacturing processes and the need for specialized instrumentation. This high cost limits their accessibility, particularly among small and mid-sized laboratories, thereby reducing overall biochips market demand. Many end users are turning to alternative technologies like immunoassays, qPCR, and next-generation sequencing (NGS) due to their accuracy and cost-efficiency. This trend may also negatively impact the biochips market growth in the coming years. Growing Adoption in Disease Diagnostics Creating Lucrative Growth Opportunities Biochips are being increasingly used in the diagnosis of cancer, genetic disorders, and infectious diseases due to their high accuracy and speed. Their rising adoption in disease diagnostics is expected to create lucrative growth opportunities for biochip manufacturers during the forecast period. Rising incidence of chronic and infectious diseases, such as COVID-19, is creating a strong need for rapid diagnostics. This is expected to drive demand for biochips, as they offer fast and multiplexed detection of pathogens, making them ideal for point-of-care testing. Get Up to 25% Discount on the US Tariff Impact Analysis Report: Impact of AI on the Biochips Market Artificial Intelligence (AI) is making a profound impact on the biochips market. It enhances data analysis, diagnostics, and personalized medicine. AI algorithms significantly improve the accuracy and speed of disease detection by rapidly interpreting complex biological data produced by biochips. This powerful combination accelerates drug discovery and enables real-time health monitoring. With ongoing advancements in AI, new applications and efficiencies are expected to emerge. This evolution is poised to propel the biochips market toward greater scalability and precision in delivering advanced healthcare solutions. Emerging Biochips Market Trends Growing trend of miniaturization is significantly impacting the biochips market value. Key manufacturers are focusing on developing compact biochips (e.g. lab-on-a-chip systems) with improved features for use in diagnostics, drug discovery, and personalized medicine. Expanding applications of biochips in drug discovery is expected to foster sales growth. Biochips are increasingly used in drug discovery processes, particularly for gene expression analysis, toxicity profiling, and target identification. These applications are crucial for accelerating pharmaceutical R&D, thereby driving market growth. There is a growing emphasis on studying genes and proteins to better understand disease mechanisms, identify potential therapeutic targets, and develop personalized medicine approaches. This will likely create a strong demand for biochips in high-throughput research. Shift toward point-of-care testing (POCT) is expected to create lucrative growth avenues for biochip companies. Portable biochips are being widely used in POCT devices for faster diagnostics at the patient's location. Ongoing advancements in biochip manufacturing will also support market expansion. Improvements in microfluidics, microarray technology, and semiconductor biochip development are significantly enhancing capabilities of biochips. Analyst's View ' The global biochips market is expected to record robust growth, owing to increasing incidence of chronic and infectious diseases, rising demand for personalized medicines, and advancements in biochip manufacturing,' said senior analyst Abhijeet Kale. Current Events and Their Impact on the Biochips Market Competitor Insights Key companies listed in biochips market report: - LinguaFlex - Inspire Medical Systems, Inc. - Medtronic - LivaNova PLC - SomnoMed - Nihon Kohden Corporation - Siesta Medical Inc. - ResMed - Koninklijke Philips N.V. - Somnowell - Nyxoah SA - Fisher & Paykel Healthcare Limited - VYAIRE - Natus Medical Incorporated - Nox Medical - Drive DeVilbiss International - CLEVELAND MEDICAL DEVICES INC. - Advanced Brain Monitoring, Inc. - CONTEC MEDICAL SYSTEMS CO., LTD Key Developments In January 2025, Coherent Corp launched its new pinhole array biochips. These biochips are specifically designed for medical diagnostics, with a strong focus on gene sequencing applications. In May 2025, Archer Materials Limited partnered with Paragraf Limited for Biochip development. This partnership is intended to help Archer advance its Biochip for at-home testing of chronic kidney disease. Market Segmentation By Product Type DNA Chips Cancer Diagnosis and Treatment Gene Expression SNP Genotyping Genomics Drug Discovery Agricultural Biotechnology Others Protein Chips Proteomics Expression Profiling Diagnostics HTS Others Lab-on-chip IVD & POC Others Tissue Arrays Cell Arrays By End User Biotechnology and Pharmaceutical Companies Academic & Research Institutes Hospitals and Diagnostic Centers Others About Us:Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries. Media Contact Company Name: Coherent Market Insights Contact Person: Mr. Shah Email: Send Email Phone: + 12524771362 Address: 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States Burlingame City: Burlingame State: California Country: United States Website:


CTV News
2 hours ago
- CTV News
Researchers meet in Lethbridge to discuss agricultural technology
Agriculture experts and researchers are in Lethbridge for a symposium, discussing how to use technology to help feed a growing world population.


CTV News
2 hours ago
- CTV News
Calls to lower colorectal cancer screening age
Winnipeg Watch Maralee speaks with Barry Stein of Colorectal Cancer Canada about their push to lower the screening age to 45 years old.